https://geneonline.news/藥廠運用自主型ai-提升效率與信任/2025-07-03T21:45:51.000Zweekly0.8 https://geneonline.news/諾華自身免疫藥物cosentyx後期試驗受挫/2025-07-03T21:20:21.000Zweekly0.8 https://geneonline.news/諾華落後艾伯維，rinvoq擴展至巨細胞動脈炎/2025-07-03T21:19:33.000Zweekly0.8 https://geneonline.news/甘迺迪遵循他解僱的acip成員的rsv建議/2025-07-03T20:45:23.000Zweekly0.8 https://geneonline.news/小羅勃甘迺迪背書擴大rsv疫苗施打對象/2025-07-03T20:44:33.000Zweekly0.8 https://geneonline.news/regeneron-lynozyfic-挑戰強生-tecvayli-注重劑量便利性與療效/2025-07-03T20:13:33.000Zweekly0.8 https://geneonline.news/regeneron雙特異性抗體獲多發性骨髓瘤批准，解鎖六億美/2025-07-03T20:13:28.000Zweekly0.8 https://geneonline.news/4dmt裁員瘦身-專注後期研發/2025-07-03T20:01:25.000Zweekly0.8 https://geneonline.news/biospace追蹤2025年裁員與重組計畫-12/2025-07-03T20:00:32.000Zweekly0.8 https://geneonline.news/biospace追蹤2025年裁員與重組動態-5/2025-07-03T19:57:32.000Zweekly0.8 https://geneonline.news/4dmt裁員-聚焦後期研發/2025-07-03T19:57:25.000Zweekly0.8 https://geneonline.news/生技領袖籲請fda維持ru486使用權/2025-07-03T19:51:28.000Zweekly0.8 https://geneonline.news/業界高層聯名譴責墮胎藥限制報告/2025-07-03T19:50:33.000Zweekly0.8 https://geneonline.news/ai驅動電郵攻擊激增-醫療機構面臨風險-2/2025-07-03T19:30:56.000Zweekly0.8 https://geneonline.news/ai驅動電郵攻擊激增-醫療機構面臨風險/2025-07-03T19:30:51.000Zweekly0.8 https://geneonline.news/haleon任命卡爾漢尼為首席研發長/2025-07-03T18:55:43.000Zweekly0.8 https://geneonline.news/hikma製藥美國公司宣布十億美元投資擴大美國製造與/2025-07-03T18:40:43.000Zweekly0.8 https://geneonline.news/pneumonia-3rd-leading-cause-of-death-in-taiwan-doctors-urge-vaccination/2026-01-26T14:59:19.000Zweekly0.8 https://geneonline.news/2025-mjtaiwan-kpmg-technology-forum-analyzing-the-new-global-strategic-situation-from-the-perspective-of-the-semiconductor-supply-chain/2025-07-15T14:22:20.000Zweekly0.8 https://geneonline.news/major-turning-points-in-the-biotech-and-pharmaceutical-industry-in-2025-market-reshaping-from-innovative-drugs-to-patent-expiration/2025-07-15T14:23:38.000Zweekly0.8 https://geneonline.news/fda批准再生元多發性骨髓瘤藥物優於嬌生輝瑞/2025-07-03T09:53:56.000Zweekly0.8 https://geneonline.news/fda批准再生元多發性骨髓瘤新藥-劑量靈活優於競品/2025-07-03T09:53:51.000Zweekly0.8 https://geneonline.news/nordic-capital-收購-arcadia-進軍生育科技領域/2025-07-03T05:26:58.000Zweekly0.8 https://geneonline.news/北歐資本收購-arcadia-進軍價值醫療領域/2025-07-03T05:25:52.000Zweekly0.8 https://geneonline.news/organon子宮內膜異位症藥物二期試驗失敗-終止開發/2025-07-03T04:17:01.000Zweekly0.8 https://geneonline.news/默沙東旗下公司子宮內膜異位藥物二期臨床試驗失/2025-07-03T04:16:51.000Zweekly0.8 https://geneonline.news/護理機構面臨壓力與展望/2025-07-02T22:15:56.000Zweekly0.8 https://geneonline.news/護理機構產業趨勢與挑戰/2025-07-02T22:15:51.000Zweekly0.8 https://geneonline.news/organon子宮內膜異位症藥物因未能改善疼痛而停產/2025-07-02T22:14:30.000Zweekly0.8 https://geneonline.news/女性健康公司九億五千四百萬美元收購藥物/2025-07-02T22:13:33.000Zweekly0.8 https://geneonline.news/醫師主導ai-解鎖事前授權臨床生產力/2025-07-02T21:29:51.000Zweekly0.8 https://geneonline.news/法官裁定衛生及公共服務部無權擅改機構結構/2025-07-02T20:54:32.000Zweekly0.8 https://geneonline.news/法院暫緩美國衛生部大規模裁員-裁定裁員可能違法/2025-07-02T20:54:26.000Zweekly0.8 https://geneonline.news/甘迺迪擬擴大疫苗傷害賠償計畫納入新冠疫苗並延/2025-07-02T20:24:33.000Zweekly0.8 https://geneonline.news/小羅勃甘迺迪擬修改疫苗傷害賠償計畫/2025-07-02T20:24:27.000Zweekly0.8 https://geneonline.news/fda考量對argenx-vyvgart-hytrulo採取監管行動-因嚴重安全疑慮/2025-07-02T20:10:23.000Zweekly0.8 https://geneonline.news/vyvgart安全更新引發股價震盪分析師稱反應過度/2025-07-02T20:09:32.000Zweekly0.8 https://geneonline.news/加州生技製造業就業人數下滑投資仍持續/2025-07-02T18:54:32.000Zweekly0.8 https://geneonline.news/加州製造業就業下滑但投資持續仍是關鍵/2025-07-02T18:54:23.000Zweekly0.8 https://geneonline.news/car-t療法擴張併購案增多迷幻藥讀數出爐最高法院裁/2025-07-02T18:19:29.000Zweekly0.8 https://geneonline.news/美國藥品政策多項重大進展/2025-07-02T18:18:34.000Zweekly0.8 https://geneonline.news/chinas-new-drug-policy-rd-payment-access-boost/2026-01-26T15:04:01.000Zweekly0.8 https://geneonline.news/吉利德雙效藥物挑戰愛滋病市場-gsk恐落後/2025-07-02T12:08:26.000Zweekly0.8 https://geneonline.news/吉利德愛滋病預防藥銷售額預估達高峰-葛蘭素史克/2025-07-02T12:07:33.000Zweekly0.8 https://geneonline.news/奧克斯納醫療導入ai工具大幅縮短預授權時間/2025-07-02T09:36:56.000Zweekly0.8 https://geneonline.news/奧克斯納健康擴大使用ai平台加速藥品事前授權流程/2025-07-02T09:36:51.000Zweekly0.8 https://geneonline.news/藥物開發ai應用-fda草案指引受關注/2025-07-02T04:47:33.000Zweekly0.8 https://geneonline.news/美國fda藥物警戒人工智能指南解析/2025-07-02T04:47:32.000Zweekly0.8 https://geneonline.news/麻省理工分拆公司syntis-bio獲3800萬美元資金開發肥胖治療/2025-07-02T01:31:58.000Zweekly0.8 https://geneonline.news/麻省理工新創syntis-bio獲3800萬美元-創新療法治療肥胖/2025-07-02T01:30:52.000Zweekly0.8 https://geneonline.news/細胞基因療法專家讚揚監管機構移除car-t療法風險評/2025-07-01T23:38:33.000Zweekly0.8 https://geneonline.news/car-t療法安全防護移除獲fda批准-受細胞基因治療界歡迎/2025-07-01T23:38:22.000Zweekly0.8 https://geneonline.news/car-t-細胞療法保護機制移除獲-fda-支持/2025-07-01T23:35:24.000Zweekly0.8 https://geneonline.news/細胞基因療法專家讚賞美國fda取消car-t療法風險評估策/2025-07-01T23:34:42.000Zweekly0.8 https://geneonline.news/lilli-health-推出多囊性卵巢症管理應用程式/2025-07-01T23:20:58.000Zweekly0.8 https://geneonline.news/lilli健康推出應用程式管理多囊性卵巢症候群/2025-07-01T23:19:51.000Zweekly0.8 https://geneonline.news/拜耳旗下bluerock裁員五十人-致力精簡架構/2025-07-01T22:42:25.000Zweekly0.8 https://geneonline.news/biospace追蹤2025年裁員及重組計畫-2/2025-07-01T22:41:33.000Zweekly0.8 https://geneonline.news/延長還款期-解決藥品可負擔性問題/2025-07-01T22:38:56.000Zweekly0.8 https://geneonline.news/延長付款期限解決藥品可負擔性問題/2025-07-01T22:38:51.000Zweekly0.8 https://geneonline.news/beckley-迷幻鼻噴劑二期抑鬱症研究結果積極/2025-07-01T21:47:01.000Zweekly0.8 https://geneonline.news/bpl003治療難治型憂鬱症展現強勁療效/2025-07-01T21:45:33.000Zweekly0.8 https://geneonline.news/環狀肽設計兼具生物製劑與小分子藥物優勢/2025-07-01T21:26:33.000Zweekly0.8 https://geneonline.news/argenx斥資逾15億美元收購unp巨環肽技術/2025-07-01T21:26:25.000Zweekly0.8 https://geneonline.news/argenx斥資逾15億美元-收購unp環狀肽技術/2025-07-01T21:24:22.000Zweekly0.8 https://geneonline.news/環狀肽設計兼具生物製劑靶向性與小分子藥物細胞/2025-07-01T21:23:33.000Zweekly0.8 https://geneonline.news/服務弱勢群體-質重於量/2025-07-01T21:10:57.000Zweekly0.8 https://geneonline.news/聯邦監管趨嚴-medicare行銷商須重視潛在客戶品質/2025-07-01T21:10:51.000Zweekly0.8 https://geneonline.news/fda批准neurogene雷特氏症關鍵研究設計/2025-07-01T20:34:40.000Zweekly0.8 https://geneonline.news/neurogene雷特氏症基因療法關鍵試驗採用嚴格標準/2025-07-01T20:34:33.000Zweekly0.8 https://geneonline.news/protagonist新藥挑戰禮來三重g促效劑/2025-07-01T19:56:34.000Zweekly0.8 https://geneonline.news/輝瑞稱二期試驗終止因招募困難與藥物安全效力無/2025-07-01T19:55:33.000Zweekly0.8 https://geneonline.news/主角公司加入肥胖治療戰局-三重作用藥丸瞄準2026年/2025-07-01T19:55:27.000Zweekly0.8 https://geneonline.news/輝瑞堅稱二期研究終止與招募困難有關與藥物安全/2025-07-01T19:51:33.000Zweekly0.8 https://geneonline.news/輝瑞終止cd47血癌藥物中期試驗-因招募問題/2025-07-01T19:51:27.000Zweekly0.8 https://geneonline.news/亞洲領先醫藥展覽廣州北京圓滿落幕/2025-07-01T18:31:43.000Zweekly0.8 https://geneonline.news/global-biotech-funding-favors-mature-assetshow-will-bio-asia-taiwan-align/2025-07-15T14:22:51.000Zweekly0.8 https://geneonline.news/libopharma-partners-with-nycu-to-accelerate-ai-cancer-drug-rd/2026-03-13T21:45:17.000Zweekly0.8 https://geneonline.news/六月收購潮推升上半年併購數據/2025-07-01T12:06:24.000Zweekly0.8 https://geneonline.news/六月併購潮推升上半年併購數據/2025-07-01T12:04:25.000Zweekly0.8 https://geneonline.news/藥廠併購交易回溫/2025-07-01T12:03:33.000Zweekly0.8 https://geneonline.news/醫療人事異動月報/2025-07-01T10:17:54.000Zweekly0.8 https://geneonline.news/醫療產業人事異動頻繁-六月高層洗牌裁員潮湧現/2025-07-01T10:16:51.000Zweekly0.8 https://geneonline.news/安進抗體藥物延長胃癌患者整體存活期/2025-07-01T03:48:20.000Zweekly0.8 https://geneonline.news/安進新藥聯合化療-延長胃癌患者存活期/2025-07-01T03:47:33.000Zweekly0.8 https://geneonline.news/艾伯維斥資21億美元擴展免疫與炎症療法產品線/2025-07-01T02:58:48.000Zweekly0.8 https://geneonline.news/艾伯維21億美元收購capstan拓展免疫細胞療法/2025-07-01T02:57:51.000Zweekly0.8 https://geneonline.news/雅創與埃森哲發布女性健康新報告/2025-07-01T00:29:51.000Zweekly0.8 https://geneonline.news/springboard-enterprises與埃森哲發布女性健康新報告/2025-07-01T00:29:49.000Zweekly0.8 https://geneonline.news/艾伯維收購capstan-therapeutics-擴大car-t療法布局/2025-06-30T23:01:33.000Zweekly0.8 https://geneonline.news/艾伯維豪擲21億美元收購capstan及其新型car-t療法/2025-06-30T23:01:23.000Zweekly0.8 https://geneonline.news/必治妥施貴寶持續裁員-新澤西州年度總數近900人/2025-06-30T22:17:18.000Zweekly0.8 https://geneonline.news/百時美施貴寶新澤西州再裁員/2025-06-30T22:16:33.000Zweekly0.8 https://geneonline.news/最佳減重營養計畫指南/2025-06-30T22:12:51.000Zweekly0.8 https://geneonline.news/最佳減重團體營養計畫指南/2025-06-30T22:12:49.000Zweekly0.8 https://geneonline.news/阿茲海默症藥物突破性批准後相關交易激增/2025-06-30T22:12:19.000Zweekly0.8 https://geneonline.news/單株抗體燃希望-藥廠搶進神經退化疾病治療/2025-06-30T22:11:33.000Zweekly0.8 https://geneonline.news/單株抗體興起-藥廠押注神經退化疾病治療/2025-06-30T22:09:33.000Zweekly0.8 https://geneonline.news/阿茲海默症藥物批准突破後相關交易激增/2025-06-30T22:09:20.000Zweekly0.8 https://geneonline.news/inmune-bio-tnf抑制劑-早期阿茲海默症炎症患者獲益/2025-06-30T21:45:33.000Zweekly0.8